Apr 6 2020 |
Novel Virus Brings Novel Coverage Theories |
ArentFox Schiff LLP |
Apr 6 2020 |
COVID-19 Liability Immunity - What You Need to Know Now |
Womble Bond Dickinson (US) LLP |
Apr 6 2020 |
EPA Takes Action to Ease the Production of Disinfectants Approved for Use Against the Novel Coronavirus |
Beveridge & Diamond PC |
Apr 6 2020 |
FDA Policy Provides Enforcement Relief Regarding Certain Medical Devices Due to Pandemic |
Beveridge & Diamond PC |
Apr 6 2020 |
EPA Highlights Enforcement Against Disinfectant Products Making Fraudulent Coronavirus Claims |
Beveridge & Diamond PC |
Apr 6 2020 |
FDA Resumes Records Review Under the FSVP Rule by Remote Inspections Instead of Onsite Visits to Importers |
Keller and Heckman LLP |
Apr 3 2020 |
COVID-19: Notable Impacts for Post-Acute Providers from the CARES Act, CMS Blanket Waivers, and the CMS Interim Final Rule |
Foley & Lardner LLP |
Apr 3 2020 |
Commercial Payors and Medicaid Telehealth Billing |
Womble Bond Dickinson (US) LLP |
Apr 3 2020 |
FDA Funding Opportunity Announcement: “Exploring the use of Real-World Data to Generate Real-World Evidence in Regulatory Decision-Making (U01) Clinical Trials Optional” |
Faegre Drinker |
Apr 3 2020 |
Legal Liability of Healthcare Providers for Care Provided During COVID-19 Pandemic |
Epstein Becker & Green, P.C. |
Apr 3 2020 |
Russian Federation Accepting Nominations to New Chemical Inventory |
Bergeson & Campbell, P.C. |
Apr 2 2020 |
CMS Issues Temporary Waivers in Broad Coronavirus Response |
Sheppard, Mullin, Richter & Hampton LLP |
Apr 2 2020 |
Class Action Ascertainability in the Eleventh Circuit: What Makes the Cut? |
Bilzin Sumberg |
Apr 2 2020 |
Doctor Fraud: False Claims and Controlled Substances an Ongoing Problem for the Medical Industry |
Stark & Stark |
Apr 2 2020 |
Strategies for Collaborating With Other Health Care Firms to Expand Production and Secure the Supply Chain |
Bracewell LLP |
Apr 2 2020 |
FDA Provides Temporary Flexibility to Chain Restaurants and Similar Retail Food Establishments in Response to COVID-19 |
Keller and Heckman LLP |
Apr 1 2020 |
Court Of Chancery Orders Specific Performance Of Merger Agreement, Finding That Fraud Contained In FDA Filings For Approval Of Target Product Did Not Rise To A “Material Adverse Effect” |
K&L Gates LLP |
Apr 1 2020 |
Gifting Goods & Services to the U.S. Government in the Wake of the Coronavirus Outbreak |
Sheppard, Mullin, Richter & Hampton LLP |
Apr 1 2020 |
TTB Steps Up Amid Crisis - Postpones Excise Tax Filing and Payment Dates |
Norris McLaughlin P.A. |
Apr 1 2020 |
Federal Judge Finds Claims Too Speculative and Dismisses “Natural” Peanut Butter Class Action |
Keller and Heckman LLP |
Apr 1 2020 |
Detailed Summary of Federal Requirements for Production of Hand Sanitizing Products |
McDermott Will & Schulte LLP |
Apr 1 2020 |
Beverage Mislabeling Suit Runs Out of Juice |
Proskauer Rose LLP |
Mar 31 2020 |
FDA Issues Guidance on Regulatory Submissions in Alternate Electronic Format, Including Type III DMFs |
Keller and Heckman LLP |
Mar 31 2020 |
TSCA Fees Rule Update – EPA Issues No Action Assurance Memorandum |
Beveridge & Diamond PC |
Mar 31 2020 |
HHS Issues Blanket Waivers for Certain Financial Relationships Subject to the Stark Law |
Epstein Becker & Green, P.C. |
Mar 31 2020 |
Utilization of Natural Phenomenon Found Patent Eligible |
Foley & Lardner LLP |
Mar 31 2020 |
FMCSA Addresses Potential Disruptions To Drug And Alcohol Testing During COVID-19 Crisis |
Jackson Lewis P.C. |
Mar 31 2020 |
New Jersey Division of Alcoholic Beverage Control Issues Guidance Concerning COVID-19 Emergency Operations |
Norris McLaughlin P.A. |
Mar 31 2020 |
COVID-19 Pandemic Prompts FDA to Offer Guidance on Diverting Human Food to Animal Food Use |
Keller and Heckman LLP |
Mar 31 2020 |
Personal Protective Equipment & Ventilators: How FDA Is Increasing Supply for the US Healthcare System |
Sheppard, Mullin, Richter & Hampton LLP |
Mar 30 2020 |
United Kingdom’s CMA Issues Guidance to Businesses on Co-Operation During the Crisis |
Proskauer Rose LLP |
Mar 30 2020 |
USCIS Announces Temporary Relief for EAD Applicants |
Jackson Lewis P.C. |
Mar 30 2020 |
Key Health Care Provisions of the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) |
Sheppard, Mullin, Richter & Hampton LLP |
Mar 30 2020 |
Consumers Allege Dishonesty from Honest Tea |
Bilzin Sumberg |
Mar 30 2020 |
FTC Paid Endorser Settlement Sets Framework for Advertiser Best Practices |
Proskauer Rose LLP |